Trials / Completed
CompletedNCT00230984
IRAD2 : Patients With Respiratory Failure at Home
Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion. This is a randomized controlled, open clinical trial with two groups. * first group, 100 patients : control group, patients followed with no add-on intervention * Second group, 100 patients : rehabilitation group with education, oral supplements, exercise and androgenic steroids.
Detailed description
Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion State of the art : The IRAD2 trial is evaluating a 3-month home intervention which includes education, oral supplements, exercise and androgenic steroids in undernourished patients with chronic respiratory failure. The main objective is to increase the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life. Secondary end-points include a reduction in exacerbation rates by 25%, a reduction in health-related costs and an increase in survival during the year following intervention. Material and methods : This interventional, multi-centre, prospective, two-armed parallel, controlled trial is being conducted in 200 patients. In both groups, "Control" and "Rehabilitation", 7 home visits are scheduled during the 3-month intervention for education purpose. In the "Rehabilitation" group, patients will receive 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women, oral dietary supplements (563 kcal/d) and exercises on an ergometric bicycle 3 to 5 times a week. Expected results : In the event of significant responses to intervention, this trial would validate a comprehensive and global home-care for undernourished patients with chronic respiratory failure combining therapeutic education, oral supplements, androgenic substitution and physical activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | education | |
| DRUG | Oral dietary supplements (563 kcal/d), RESPIFOR | |
| BEHAVIORAL | exercises on an ergometric bicycle 3 to 5 times a week | |
| DRUG | 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2005-10-03
- Last updated
- 2009-07-08
Locations
8 sites across 2 countries: France, Switzerland
Source: ClinicalTrials.gov record NCT00230984. Inclusion in this directory is not an endorsement.